IIB 

118TH CONGRESS 

2D SESSION H. R. 9598 

IN THE SENATE OF THE UNITED STATES 

DECEMBER 9, 2024 

Received; read twice and referred to the Committee on the Judiciary 

AN ACT 

To amend the Office of National Drug Control Policy Reauthorization Act to reauthorize such Office, and for other 

purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


ssavage on LAPJG3WLY3PROD with BILLS
2 

HR 9598 RFS

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Office of National 

3 Drug Control Policy Reauthorization Act of 2024’’. 

4 SEC. 2. OFFICE OF NATIONAL DRUG CONTROL POLICY RE5 AUTHORIZATION. 

6 (a) AMENDMENTS TO THE OFFICE OF NATIONAL

7 DRUG CONTROL POLICY REAUTHORIZATION ACT OF

8 1998.—The Office of National Drug Control Policy Reau9 thorization Act of 1998 (21 U.S.C. 1701 et seq.) is 

10 amended— 

11 (1) in section 702 (21 U.S.C. 1701)— 

12 (A) in paragraph (2)(A)(ii), by striking 

13 ‘‘Government Reform’’ and inserting ‘‘Account14 ability’’; 

15 (B) in paragraph (3)— 

16 (i) in subparagraph (L), by striking ‘‘; 

17 and’’ and inserting a semicolon; 

18 (ii) in subparagraph (M), by striking 

19 the period at the end and inserting ‘‘; 

20 and’’; and 

21 (iii) by adding at the end the fol22 lowing: 

23 ‘‘(N) tertiary prevention support or serv24 ices, including opioid antagonists or overdose 

25 reversal agents such as naloxone, and other 


ssavage on LAPJG3WLY3PROD with BILLS
3 

HR 9598 RFS

1 harm reduction activities such as overdose and 

2 drug detection testing.’’; 

3 (C) by amending paragraph (7) to read as 

4 follows:; 

5 ‘‘(7) EMERGING DRUG THREAT.—The term 

6 ‘emerging drug threat’ means the occurrence of a 

7 new and growing trend in the illicit use or misuse 

8 of a drug, class of drugs, or non-controlled sub9 stance, or a new or evolving method of drug con10 sumption or trafficking, including rapid expansion in 

11 the supply of or demand for such a drug or sub12 stance.’’. 

13 (D) in paragraph (9), by striking ‘‘drug 

14 laws’’ and inserting the following: ‘‘drug, trade, 

15 and illicit drug trafficking laws’’; 

16 (E) in paragraph (10), by inserting after 

17 ‘‘demand reduction,’’ the following: ‘‘illicit drug 

18 trafficking,’’; 

19 (F) by redesignating paragraphs (15), 

20 (16), and (17) as paragraphs (17), (18), and 

21 (19), respectively; 

22 (G) by inserting after paragraph (14) the 

23 following new paragraph: 

24 ‘‘(15) PRECURSOR CHEMICAL.— 


ssavage on LAPJG3WLY3PROD with BILLS
4 

HR 9598 RFS

1 ‘‘(A) IN GENERAL.—The term ‘precursor 

2 chemical’ includes a listed chemical and an un3 regulated precursor. 

4 ‘‘(B) LISTED CHEMICAL.—The term ‘listed 

5 chemical’ has the meaning given that term in 

6 section 102 of the Controlled Substances Act 

7 (21 U.S.C. 802). 

8 ‘‘(C) UNREGULATED PRECURSOR.—The 

9 term ‘unregulated precursor’— 

10 ‘‘(i) means any chemical used in the 

11 production of illicit drugs that has not 

12 been identified as a listed chemical under 

13 the Controlled Substances Act; and 

14 ‘‘(ii) does not include a solvent or rea15 gent. 

16 ‘‘(16) STATE.—The term ‘State’ means each of 

17 the several States of the United States, the District 

18 of Columbia, and each territory or possession of the 

19 United States.’’; 

20 (H) in paragraph (19), as so redesig21 nated— 

22 (i) by redesignating subparagraphs 

23 (G) and (H) as subparagraphs (H) and 

24 (I), respectively; and 


ssavage on LAPJG3WLY3PROD with BILLS
5 

HR 9598 RFS

1 (ii) by inserting after subparagraph 

2 (F) the following: 

3 ‘‘(G) activities to map, track, dismantle, 

4 and disrupt the financial enablers of drug traf5 ficking organizations, transnational criminal or6 ganizations, and money launderers involved in 

7 the manufacture and trafficking of drugs in the 

8 United States and in foreign countries;’’; and 

9 (I) by inserting at the end the following: 

10 ‘‘(20) UNITED STATES.—The term ‘United 

11 States’, when used in a geographical sense, means 

12 all of the States, the District of Columbia, and the 

13 territories and possessions of the United States, and 

14 any waters within the jurisdiction of the United 

15 States. 

16 ‘‘(21) EVIDENCE.—The term ‘evidence’ has the 

17 meaning given that term in section 3561 of title 44, 

18 United States Code.’’; 

19 (2) in section 703(d) (21 U.S.C. 1702(d))— 

20 (A) in paragraph (5)(B), by striking ‘‘ac21 cepted by a contractor to be used in its per22 formance of a contract for the Office.’’ and in23 serting the following: ‘‘accepted— 


ssavage on LAPJG3WLY3PROD with BILLS
6 

HR 9598 RFS

1 ‘‘(i) by a contractor (or subcontractor 

2 thereof at any tier) for use in its perform3 ance of a contract for the Office; or 

4 ‘‘(ii) by a grant recipient (or sub5 grantee thereof at any tier) for use in car6 rying out an award related to a fund ad7 ministered by the Office.’’; and 

8 (B) in paragraph (6), by inserting after 

9 ‘‘paragraph (5)’’ the following: ‘‘and the reg10 istry shall be sent to the appropriate Congres11 sional committees’’; 

12 (3) in section 704 (21 U.S.C. 1703)— 

13 (A) in subsection (a)(1)(C), by striking 

14 ‘‘shall’’ and inserting ‘‘may’’; 

15 (B) in subsection (b)— 

16 (i) in paragraph (16), by inserting 

17 after ‘‘to treat addiction’’ the following: ‘‘, 

18 encourage primary substance use preven19 tion, and increase accessibility and effec20 tiveness of life-saving opioid antagonists or 

21 reversal agents, such as naloxone’’; 

22 (ii) by striking paragraph (20); 

23 (iii) by redesignating paragraph (21) 

24 as paragraph (20); 


ssavage on LAPJG3WLY3PROD with BILLS
7 

HR 9598 RFS

1 (iv) in paragraph (20), as so redesig2 nated, by striking the period at the end 

3 and inserting ‘‘; and’’; and 

4 (v) by inserting at the end the fol5 lowing: 

6 ‘‘(21) shall coordinate with the Secretary of 

7 Homeland Security, the Attorney General, and the 

8 Secretary of State regarding the status of the en9 forcement of clauses (i) and (ii) of subparagraph (A) 

10 and subparagraph (B) of section 237(a)(2) (8 

11 U.S.C. 1227(a)(2)) and subparagraphs (A) and (C) 

12 of section 212(a)(2) (8 U.S.C. 1182(a)(2)) for the 

13 purposes of ensuring such drug control and illicit 

14 drug trafficking enforcement activities are ade15 quately resourced.’’; 

16 (C) in subsection (c)— 

17 (i) in paragraph (1)(C), by striking 

18 ‘‘supply reduction, and State, local, and 

19 tribal affairs, including any drug law en20 forcement activities’’ and inserting the fol21 lowing: ‘‘supply reduction, accessibility to 

22 life-saving opioid antagonists or reversal 

23 agents, such as naloxone, and State, local, 

24 and Tribal affairs, including any drug re25 lated law enforcement activities’’; 


ssavage on LAPJG3WLY3PROD with BILLS
8 

HR 9598 RFS

1 (ii) in paragraph (3)(C)— 

2 (I) in clause (ii), by inserting 

3 after ‘‘United States’’ the following: ‘‘, 

4 including at and between the ports of 

5 entry,’’; 

6 (II) in clause (iii), by striking ‘‘; 

7 and’’ and inserting a semicolon; 

8 (III) in clause (iv), by striking 

9 the period at the end and inserting ‘‘; 

10 and’’; and 

11 (IV) by inserting at the end the 

12 following new clause: 

13 ‘‘(v) requests funding for activities 

14 that facilitate illicit drug use, but not in15 cluding overdose reversal medications, drug 

16 checking, or testing technology.’’; 

17 (D) in subsection (d)(8)(F)(ii), by striking 

18 ‘‘and at United States ports of entry by officers 

19 and employees of National Drug Control Pro20 gram agencies and domestic and foreign law en21 forcement officers’’ and inserting the following: 

22 ‘‘and at and between United States ports of 

23 entry by officers and employees of National 

24 Drug Control Program agencies and domestic 

25 and foreign law enforcement officers’’; 


ssavage on LAPJG3WLY3PROD with BILLS
9 

HR 9598 RFS

1 (E) in subsection (i)— 

2 (i) in paragraph (1)(A), by striking 

3 ‘‘to address illicit drug use issues’’ and in4 serting the following: ‘‘to address illicit 

5 drug use, prevention and treatment of 

6 overdose and addiction, and law enforce7 ment activities’’; and 

8 (ii) in paragraph (2), by striking 

9 ‘‘2023’’ and inserting ‘‘2031’’; and 

10 (F) in subsection (k)— 

11 (i) in the heading, by striking ‘‘HARM

12 REDUCTION PROGRAMS’’ and inserting 

13 ‘‘SUBSTANCE USE PREVENTION, HARM

14 REDUCTION, AND LIFE-SAVING TREAT15 MENT PROGRAMS’’; and 

16 (ii) in the first sentence, by inserting 

17 after ‘‘drug addiction and use’’ the fol18 lowing: ‘‘with the primary goal being the 

19 prevention of initial or continued use and 

20 the fostering of life-saving opioid antago21 nists or reversal agents, such as naloxone’’; 

22 (4) in section 705 (21 U.S.C. 1704)— 

23 (A) in subsection (a)(3)— 

24 (i) in subparagraph (A), by inserting 

25 after ‘‘Federal Government’’ the following: 


ssavage on LAPJG3WLY3PROD with BILLS
10 

HR 9598 RFS

1 ‘‘and such lands owned by a foreign prin2 cipal (as such term in defined in section 

3 1(b) of the Foreign Agents Registration 

4 Act of 1938 (22 U.S.C. 611))’’; 

5 (ii) in subparagraph (B)— 

6 (I) by inserting after ‘‘the pre7 ceding year’’ the following: ‘‘, along 

8 with historical comparisons over the 

9 prior 20 years,’’; 

10 (II) in clause (i)— 

11 (aa) by inserting after ‘‘seiz12 ing drugs,’’ the following: ‘‘in13 cluding precursor chemicals,’’; 

14 and 

15 (bb) by striking ‘‘; and’’ and 

16 inserting a semicolon; 

17 (III) in clause (ii), by striking 

18 the period at the end and inserting ‘‘; 

19 and’’; and 

20 (IV) by inserting at the end the 

21 following new clause: 

22 ‘‘(iii) the effects of trends of encoun23 ters of inadmissible aliens at and between 

24 the ports of entry, and the effect of any in25 creases or changes in the level of trade and 


ssavage on LAPJG3WLY3PROD with BILLS
11 

HR 9598 RFS

1 travel, on the capacity and ability of the 

2 Department of Homeland Security compo3 nents to interdict and prevent the unlawful 

4 entry of illicit drugs into the United States 

5 by any means.’’; and 

6 (iii) in subparagraph (D)— 

7 (I) by inserting after ‘‘the pre8 ceding year’’ the following: ‘‘, along 

9 with historical comparisons over the 

10 prior 20 years,’’; and 

11 (II) in clause (iii), by inserting 

12 after ‘‘seizing drugs,’’ the following: 

13 ‘‘including precursor chemicals,’’; 

14 (B) in subsection (e)(2), by inserting be15 fore the period at the end the following: ‘‘and 

16 $3,000,000 for each of fiscal years 2025 

17 through 2031’’; and 

18 (C) in subsection (f)— 

19 (i) in paragraph (2), by inserting after 

20 ‘‘agency shall’’ the following: ‘‘, in accord21 ance with guidelines issued by the Director 

22 for standard definitions, identification, and 

23 review procedures,’’; and 

24 (ii) by striking paragraph (4); 

25 (5) in section 706 (21 U.S.C. 1705)— 


ssavage on LAPJG3WLY3PROD with BILLS
12 

HR 9598 RFS

1 (A) in subsection (c)— 

2 (i) in paragraph (1)— 

3 (I) by striking subparagraph (D); 

4 (II) in subparagraph (H)— 

5 (aa) by inserting after 

6 ‘‘identifying existing’’ the fol7 lowing: ‘‘evidence,’’; and 

8 (bb) by striking ‘‘will obtain 

9 such data’’ and inserting ‘‘will 

10 ensure such data is obtained’’; 

11 (III) in subparagraph (J)(ii), by 

12 inserting ‘‘evidence,’’ before ‘‘data’’; 

13 (IV) in subparagraph (L), by in14 serting ‘‘evidence’’ after ‘‘Such other’’; 

15 and 

16 (V) in subparagraph (M)(iv), by 

17 inserting ‘‘storing and retrieving,’’ 

18 after ‘‘collecting,’’; 

19 (ii) in paragraph (2)— 

20 (I) by redesignating subpara21 graphs (E) and (F) as subparagraphs 

22 (G) and (H), respectively; and 

23 (II) by inserting after subpara24 graph (D) the following new subpara25 graphs: 


ssavage on LAPJG3WLY3PROD with BILLS
13 

HR 9598 RFS

1 ‘‘(E) The Administrator of the Office of 

2 Information and Regulatory Affairs. 

3 ‘‘(F) The Chief Data Officers Council.’’; 

4 (iii) in paragraph (3)— 

5 (I) in subparagraph (B)(ii)— 

6 (aa) in subclause (I), by 

7 striking ‘‘; and’’ and inserting a 

8 semicolon; 

9 (bb) in subclause (II), by 

10 striking the period at the end 

11 and inserting ‘‘; and’’; and 

12 (cc) by inserting at the end 

13 the following new subclause: 

14 ‘‘(III) an analysis of the effects 

15 of trends of encounters of inadmis16 sible aliens at and between the ports 

17 of entry, and the effect of any in18 creases or changes in the level of 

19 trade and travel, on the capacity and 

20 ability of the Department of Home21 land Security to interdict and prevent 

22 the unlawful entry of illicit drugs into 

23 the United States by any means.’’; 

24 and 


ssavage on LAPJG3WLY3PROD with BILLS
14 

HR 9598 RFS

1 (II) by adding at the end the fol2 lowing new subparagraph: 

3 ‘‘(D) REQUIREMENT FOR CARIBBEAN BOR4 DER COUNTERNARCOTICS STRATEGY.— 

5 ‘‘(i) PURPOSES.—The Caribbean Bor6 der Counternarcotics Strategy shall— 

7 ‘‘(I) set forth the strategy of the 

8 Federal Government for preventing 

9 the illegal trafficking of drugs through 

10 the Caribbean region into the United 

11 States, including through ports of 

12 entry, between ports of entry, and 

13 across air and maritime approaches; 

14 ‘‘(II) state the specific roles and 

15 responsibilities of each relevant Na16 tional Drug Control Program agency 

17 for implementing the strategy; 

18 ‘‘(III) identify the specific re19 sources required to enable the relevant 

20 National Drug Control Program agen21 cies to implement the strategy, to the 

22 extent practicable; and 

23 ‘‘(IV) be designed to promote, 

24 and not hinder, legitimate trade and 

25 travel. 


ssavage on LAPJG3WLY3PROD with BILLS
15 

HR 9598 RFS

1 ‘‘(ii) SPECIFIC CONTENT RELATED TO

2 PUERTO RICO AND THE UNITED STATES

3 VIRGIN ISLANDS.—The Caribbean Border 

4 Counternarcotics Strategy shall include— 

5 ‘‘(I) a strategy to prevent the il6 legal trafficking of drugs to or 

7 through Puerto Rico and the United 

8 States Virgin Islands, including meas9 ures to substantially reduce drug-re10 lated violent crime on such islands; 

11 and 

12 ‘‘(II) recommendations for addi13 tional assistance or authorities, if any, 

14 needed by Federal, State, and local 

15 law enforcement agencies relating to 

16 the strategy, including an evaluation 

17 of Federal technical and financial as18 sistance, infrastructure capacity build19 ing, and interoperability deficiencies.’’; 

20 and 

21 (iv) in paragraph (5), by striking 

22 ‘‘data’’ each place it appears and inserting 

23 ‘‘evidence, data,’’; 

24 (B) in subsection (f)— 


ssavage on LAPJG3WLY3PROD with BILLS
16 

HR 9598 RFS

1 (i) in paragraph (1), by striking ‘‘pub2 licly available in a machine-readable for3 mat’’ and inserting the following: ‘‘publicly 

4 available as an open Government data 

5 asset (as such term is defined in section 

6 3502 of title 44, United States Code)’’; 

7 (ii) in paragraph (2), by inserting 

8 after ‘‘searchable format’’ the following: 

9 ‘‘available for bulk download to the extent 

10 practicable’’; and 

11 (iii) by amending paragraph (3) to 

12 read as follows: 

13 ‘‘(3) DATA.—The data included in the Drug 

14 Control Data Dashboard shall be updated annually 

15 with final data, and to the extent practicable, up16 dated quarterly with provisional data, that aligns 

17 with the goals of the performance measurement sys18 tem required under subsection (h) and include, at a 

19 minimum, the following: 

20 ‘‘(A) For each substance identified by the 

21 Director as having a significant impact on illicit 

22 drug use in the United States, data sufficient 

23 to— 


ssavage on LAPJG3WLY3PROD with BILLS
17 

HR 9598 RFS

1 ‘‘(i) assess supply reduction efforts, 

2 including, to the extent practicable, the 

3 total amount of substances seized; 

4 ‘‘(ii) assess drug use behaviors; 

5 ‘‘(iii) estimate the prevalence of sub6 stance use disorders; 

7 ‘‘(iv) show the number of fatal and 

8 non-fatal overdoses; and 

9 ‘‘(v) assess the provision of substance 

10 use disorder treatment. 

11 ‘‘(B) Any quantifiable measures the Direc12 tor determines to be appropriate to detail 

13 progress toward the achievement of the goals of 

14 the National Drug Control Strategy, including, 

15 to the extent practicable, data disaggregated by 

16 specific geographic areas or sub-populations of 

17 interest. 

18 ‘‘(C) Data sufficient to assess the effective19 ness of such substance use disorder treatments. 

20 ‘‘(D) To the extent practicable, data suffi21 cient to show the extent of prescription drug di22 version, trafficking, and misuse in the calendar 

23 year and each of the previous 3 calendar years. 

24 ‘‘(E) Any quantifiable measures the Direc25 tor determines to be appropriate to detail 


ssavage on LAPJG3WLY3PROD with BILLS
18 

HR 9598 RFS

1 progress toward the achievement of the goals of 

2 the National Drug Control Strategy, including 

3 to the extent practicable, data disaggregated by 

4 specific geographic areas or sub-populations of 

5 interest.’’; and 

6 (C) in subsection (g)(2)— 

7 (i) in subparagraph (D), by striking 

8 ‘‘narcotics’’ and inserting ‘‘drugs’’; 

9 (ii) in subparagraph (E), by striking 

10 ‘‘drug use’’ and inserting ‘‘illicit drug use 

11 and misuse’’; and 

12 (iii) in subparagraph (F), by striking 

13 ‘‘drug use’’ and inserting ‘‘illicit drug use 

14 and misuse’’; 

15 (6) in section 707 (21 U.S.C. 1706)— 

16 (A) in subsection (l)(2)(F), by inserting 

17 ‘‘and authorities enforcing illicit drug traf18 ficking laws’’ after ‘‘task forces’’; 

19 (B) in subsection (m)(2), by inserting ‘‘, 

20 authorities enforcing illicit drug trafficking 

21 laws,’’ after ‘‘agencies’’; 

22 (C) in subsection (p)— 

23 (i) in paragraph (5). by striking ‘‘; 

24 and’’ and inserting a semicolon; 


ssavage on LAPJG3WLY3PROD with BILLS
19 

HR 9598 RFS

1 (ii) in paragraph (6), by striking the 

2 period at the end and inserting ‘‘; and’’; 

3 and 

4 (iii) by inserting at the end the fol5 lowing new paragraph: 

6 ‘‘(7) $298,579,000 for each of fiscal years 2025 

7 through 2031.’’; 

8 (D) in subsection (r)(3), by striking ‘‘ad9 diction’’; 

10 (E) in subsection (s)— 

11 (i) in the matter before paragraph 

12 (1), by striking ‘‘The Director’’ and insert13 ing ‘‘Except as provided in subsection 

14 (t)(2), the Director’’; 

15 (ii) in paragraph (2), by striking ‘‘; 

16 and’’ and inserting a semicolon; 

17 (iii) in paragraph (3), by striking the 

18 period at the end and inserting ‘‘; and’’; 

19 and 

20 (iv) by adding at the end the fol21 lowing: 

22 ‘‘(4) enhancing fentanyl seizure and interdiction 

23 activities.’’; and 

24 (F) by adding at the end the following: 


ssavage on LAPJG3WLY3PROD with BILLS
20 

HR 9598 RFS

1 ‘‘(t) SUPPLEMENTAL GRANTS FOR FENTANYL

2 INTERDICTION ACTIVITIES.— 

3 ‘‘(1) MINIMUM ALLOCATION OF FUNDS FOR

4 FENTANYL INTERDICTION ACTIVITIES.—Of the 

5 amounts allocated for grants under subsection (s), 

6 not less than $5,000,000 shall be allocated for the 

7 purpose of making grants under subsection (s)(4). 

8 ‘‘(2) ADDITIONAL FUNDS.—In addition to 

9 amounts allocated under subparagraph (A) for the 

10 purpose of making grants under subsection (s)(4), 

11 the Director may use amounts otherwise appro12 priated to carry out this section for such purpose. 

13 ‘‘(u) ADDITIONAL JUDICIARY PROSECUTORIAL RE14 SOURCES.— 

15 ‘‘(1) TEMPORARY REASSIGNMENT OF ASSIST16 ANT UNITED STATES ATTORNEYS.— 

17 ‘‘(A) AUTHORITY.—The Attorney General 

18 may identify assistant United States attorneys 

19 who may be made available for temporary reas20 signment under subsection (b)(2) for a period 

21 of time determined by the Attorney General in 

22 coordination with the Director, during which an 

23 assistant United States attorney shall prioritize 

24 the investigation and prosecution of organizaVerDate Sep 11 2014 02:27 Dec 10, 2024 Jkt 059200 PO 00000 Frm 00020 Fmt 6652 Sfmt 6201 E:\BILLS\H9598.RFS H9598

ssavage on LAPJG3WLY3PROD with BILLS
21 

HR 9598 RFS

1 tions and individuals trafficking in fentanyl or 

2 fentanyl analogues. 

3 ‘‘(B) EXTENSION OF REASSIGNMENT.— 

4 Such reassignment may be extended by the At5 torney General for such time as may be nec6 essary to conclude any ongoing investigation or 

7 prosecution in which the assistant United 

8 States attorney is engaged. 

9 ‘‘(2) PROCESS FOR TEMPORARY REASSIGN10 MENT.—The Attorney General may establish a proc11 ess under which the Director, in consultation with 

12 the Executive Boards of each designated high inten13 sity drug trafficking area, may request such an as14 sistant United States attorney to be so temporarily 

15 reassigned. 

16 ‘‘(v) USE OF FUNDS TO COMBAT FENTANYL TRAF17 FICKING.— 

18 ‘‘(1) REQUIREMENT.—As part of the docu19 mentation that supports the President’s annual 

20 budget request for the Office, the Director shall sub21 mit to Congress a report describing the use of 

22 HIDTA funds for the purposes of enhancing 

23 fentanyl seizure and interdiction activities under 

24 subsection (s)(4) or (t) and to investigate and pros25 ecute organizations and individuals trafficking in 


ssavage on LAPJG3WLY3PROD with BILLS
22 

HR 9598 RFS

1 fentanyl or fentanyl analogues in the prior calendar 

2 year. 

3 ‘‘(2) CONTENTS.—The report shall include— 

4 ‘‘(A) the amounts of fentanyl or fentanyl 

5 analogues seized by HIDTA-funded initiative in 

6 the area during the previous year; and 

7 ‘‘(B) law enforcement intelligence and pre8 dictive data from the Drug Enforcement Ad9 ministration showing patterns and trends in 

10 abuse, trafficking, and transportation in 

11 fentanyl and fentanyl analogues. 

12 ‘‘(w) PROTECTION FROM UNREASONABLE SEARCH

13 AND SEIZURE.—Any program or activity that receives 

14 funds made available under this section shall be conducted 

15 in a manner consistent with the requirements of the 

16 Fourth Amendment to the Constitution of the United 

17 States. 

18 ‘‘(x) REPORT ON DATA ANALYTICAL SERVICES PRO19 GRAM.— 

20 ‘‘(1) REPORT.—With respect to the Data Ana21 lytical Services program (formally known as Hemi22 sphere), and any successor program, the Director 

23 shall submit to the Committee on Oversight and Ac24 countability and the Committee on the Judiciary of 

25 the House of Representatives, and the Committee on 


ssavage on LAPJG3WLY3PROD with BILLS
23 

HR 9598 RFS

1 the Judiciary of the Senate a report every two years 

2 on any activities of the program— 

3 ‘‘(A) funded by the Office; and 

4 ‘‘(B) carried out in two years prior to the 

5 submission of the report. 

6 ‘‘(2) CONTENTS OF REPORT.—The report re7 quired by paragraph (1) shall include the following: 

8 ‘‘(A) A documentation of any activities of 

9 the Data Analytical Services program, includ10 ing— 

11 ‘‘(i) the amount of searches conducted 

12 for each HIDTA; and 

13 ‘‘(ii) each requesting local law enforce14 ment jurisdiction. 

15 ‘‘(B) Information on how the program was 

16 funded and how funds were expended under the 

17 program, including information on any— 

18 ‘‘(i) funding sources derived from 

19 each HIDTA’s funding allocation for a 

20 HIDTA, or any other source of funding, 

21 for the program; and 

22 ‘‘(ii) payments made by the program 

23 to any non-governmental entity or external 

24 vendor. 


ssavage on LAPJG3WLY3PROD with BILLS
24 

HR 9598 RFS

1 ‘‘(C) A description of any policies and 

2 guidelines provided to HIDTA personnel and 

3 local law enforcement jurisdictions governing 

4 the operation of the program in order to ensure 

5 that such program does not infringe on rights 

6 protected under the Fourth Amendment or vio7 late legally protected privacy of United States 

8 citizens or individuals legally in the United 

9 States, along with any recommendations by the 

10 Director to strengthen such policies and guide11 lines.’’; 

12 (7) in section 709(f)(1) (21 U.S.C. 

13 1708(f)(1))— 

14 (A) by striking ‘‘shall’’ and inserting 

15 ‘‘may’’; 

16 (B) in subparagraph (A), by striking 

17 ‘‘abuse’’ and inserting ‘‘use or misuse’’; and 

18 (C) in subparagraph (D)(i), by striking 

19 ‘‘addiction issues’’ and inserting ‘‘substance use 

20 disorders’’; 

21 (8) in section 709 (21 U.S.C. 1708)— 

22 (A) in subsection (f)(2)(B)(iii), by insert23 ing after ‘‘professionals’’ the following: ‘‘includ24 ing experts in evidence-based media campaigns, 

25 education, and evaluation’’; and 


ssavage on LAPJG3WLY3PROD with BILLS
25 

HR 9598 RFS

1 (B) in subsection (g), by striking ‘‘2023’’ 

2 and inserting ‘‘2031’’; 

3 (9) in section 711 (21 U.S.C. 1710), including 

4 the headings, by striking ‘‘Command and Control 

5 Plan’’ each place it appears and inserting ‘‘Strategic 

6 Plan’’; and 

7 (10) in section 714 (21 U.S.C. 1711), by insert8 ing before the period at the end the following: ‘‘and 

9 $20,000,000 for each of fiscal years 2025 through 

10 2031’’. 

11 (b) AMENDMENTS TO THE ANTI-DRUG ABUSE ACT

12 OF 1988.—The Anti-Drug Abuse Act of 1988 (Public Law 

13 100–690) is amended— 

14 (1) in section 1024 (21 U.S.C. 1524)— 

15 (A) in subsection (a), by inserting before 

16 the period at the end the following: ‘‘and 

17 $109,000,000 for each of fiscal years 2025 

18 through 2031’’; and 

19 (B) in subsection (b), by striking ‘‘8 per20 cent’’ and inserting ‘‘10 percent’’; and 

21 (2) in section 1032(b) (21 U.S.C. 1532(b))— 

22 (A) by striking ‘‘$125,000’’ each place the 

23 term appears and inserting ‘‘$150,000’’; and 

24 (B) in paragraph (3)— 


ssavage on LAPJG3WLY3PROD with BILLS
26 

HR 9598 RFS

1 (i) by striking subparagraph (A) and 

2 inserting the following: 

3 ‘‘(A) IN GENERAL.—Subject to subpara4 graph (F), the Administrator may award up to 

5 2 additional grants under this paragraph to an 

6 eligible coalition awarded a grant under para7 graph (1) or (2) for any first fiscal year after 

8 the end of the 4-year or 9-year period following 

9 the period of the initial or subsequent grant 

10 under paragraph (1) or (2), as the case may 

11 be.’’; 

12 (ii) in subparagraph (B), by striking 

13 ‘‘a renewal grant’’ and inserting ‘‘up to 2 

14 renewal grants’’; 

15 (iii) in subparagraph (C), by striking 

16 ‘‘an additional grant’’ and inserting ‘‘the 

17 additional grants’’; and 

18 (iv) by striking subparagraph (D) and 

19 inserting the following: 

20 ‘‘(D) RENEWAL GRANTS.—Subject to sub21 paragraph (F), the Administrator may award a 

22 renewal grant to a grant recipient under this 

23 paragraph for each fiscal year of the 4-fiscal24 year period following the first fiscal year for 

25 which an additional grant under this paragraph 


ssavage on LAPJG3WLY3PROD with BILLS
27 

HR 9598 RFS

1 is awarded in an amount not to exceed the 

2 amount of non-Federal funds raised by the coa3 lition, including in-kind contributions, for that 

4 fiscal year.’’. 

5 (c) REAUTHORIZATION OF THE NATIONAL COMMU6 NITY ANTI-DRUG COALITION INSTITUTE.—Section 4(d) 

7 of Public Law 107–82 (21 U.S.C. 1521 note) is amended 

8 by striking paragraph (2) and inserting the following: 

9 ‘‘(2) DISBURSEMENT.—The Director shall, 

10 using amounts authorized to be appropriated by sec11 tion 1024 of the Anti-Drug Abuse Act of 1988 (21 

12 U.S.C. 1524), disburse $2,500,000 made available 

13 under subsection (a), for each of the fiscal years 

14 2025 through 2031.’’. 

15 (d) REAUTHORIZATION OF COMMUNITY-BASED COA16 LITION ENHANCEMENT GRANTS TO ADDRESS LOCAL

17 DRUG CRISES.—Section 103 of the Comprehensive Addic18 tion and Recovery Act of 2016 (21 U.S.C. 1536) is 

19 amended— 

20 (1) in subsection (a)— 

21 (A) in paragraph (1)— 

22 (i) in the heading, by striking ‘‘AD23 MINISTRATOR’’ and inserting ‘‘ASSISTANT

24 SECRETARY’’; and 


ssavage on LAPJG3WLY3PROD with BILLS
28 

HR 9598 RFS

1 (ii) by striking ‘‘Administrator’’ each 

2 place it appears and inserting ‘‘Assistant 

3 Secretary’’; 

4 (B) in paragraph (4)(B), by striking 

5 ‘‘abuse’’ and inserting ‘‘use or misuse’’; and 

6 (C) in paragraph (5)(A), by striking 

7 ‘‘abuse’’ and inserting ‘‘use or misuse’’; 

8 (2) in subsection (b), by striking ‘‘Adminis9 trator’’ and inserting ‘‘Assistant Secretary’’; 

10 (3) in subsection (h), by striking ‘‘Adminis11 trator’’ and inserting ‘‘Assistant Secretary’’; and 

12 (4) in subsection (i), by inserting before the pe13 riod at the end the following: ‘‘and $5,200,000 for 

14 each of fiscal years 2025 through 2031’’. 

15 (e) REPORT REGARDING LIFE-SAVING OPIOID AN16 TAGONISTS OR REVERSAL AGENTS.— 

17 (1) AMENDMENT.—The Office of National 

18 Drug Control Policy Reauthorization Act of 2006 

19 (Public Law 109–469) is amended by adding at the 

20 end the following new section: 

21 ‘‘SEC. 1121. REQUIREMENT FOR LIFE SAVING OPIOID OVER22 DOSE REVERSAL STUDY. 

23 ‘‘(a) FINDING.—Congress finds that it is vital to sup24 port access to treatment and emergency intervention tools 

25 to address drug addiction while also pursuing strategies 


ssavage on LAPJG3WLY3PROD with BILLS
29 

HR 9598 RFS

1 to ensure communities have readily available access to life2 saving drug overdose reversal medications, including 

3 opioid antagonists or reversal agents, such as naloxone, 

4 in case of an emergency. 

5 ‘‘(b) REPORT.—Not later than 180 days after the 

6 date of the enactment of this section, the Director of the 

7 Office of National Drug Control Policy shall submit to 

8 Congress a report that contains the following: 

9 ‘‘(1) A summary of the relevant roles, respon10 sibilities, and authorities of each relevant National 

11 Drug Control Program agency to ensure that life12 saving drug overdose reversal medications are read13 ily available in case of an emergency, including life14 saving opioid antagonists or reversal agents, such as 

15 naloxone, across the Nation. 

16 ‘‘(2) A strategy for the Federal Government to 

17 ensure that State, local, and Tribal governments, 

18 and agencies thereof including law enforcement and 

19 public health and safety entities, have life-saving 

20 drug overdose reversal medications readily available 

21 in case of an emergency, including life-saving opioid 

22 antagonists or reversal agents, such as naloxone, 

23 which at a minimum identifies— 

24 ‘‘(A) any Federal and State policies and 

25 actions necessary for the relevant National 


ssavage on LAPJG3WLY3PROD with BILLS
30 

HR 9598 RFS

1 Drug Control Program agencies to take to ad2 dress— 

3 ‘‘(i) the challenges faced by phar4 macists, prescription drug providers, dis5 pensers (including manufacturers, distribu6 tors, and retailers), and other health care 

7 providers, to make such medications read8 ily available to patients over the counter 

9 for emergency use; 

10 ‘‘(ii) the challenges faced by phar11 macists, health care providers, and State 

12 health officials to educate the public on the 

13 risks and benefits of such medications, in14 cluding how to effectively use such medica15 tions; and 

16 ‘‘(iii) the appropriate training of State 

17 and local health care providers and first 

18 responders on the use of such medications; 

19 and 

20 ‘‘(B) identifies any budgetary resources, 

21 personnel resources, licensing requirements, and 

22 legal authorities that relevant National Drug 

23 Control Program agencies needs to enable the 

24 availability of such life-saving emergency drug 

25 overdose medications; 


ssavage on LAPJG3WLY3PROD with BILLS
31 

HR 9598 RFS

1 ‘‘(3) A summary of policies in effect before the 

2 submission of the report that are administered by— 

3 ‘‘(A) the Director of the Office National 

4 Drug Control Policy; 

5 ‘‘(B) the Secretary of Health and Human 

6 Services; and 

7 ‘‘(C) each National Drug Control Program 

8 agency, as applicable. 

9 ‘‘(4) A summary of the specific actions taken 

10 over the previous 10 years before the submission of 

11 the report by the Substance Abuse and Mental 

12 Health Services Administration and the Drug En13 forcement Administration to coordinate with one an14 other and with State health agencies to ensure 

15 that— 

16 ‘‘(A) such treatments, including medica17 tions, are accessible to the public; and 

18 ‘‘(B) appropriate public education on the 

19 use of, and the risks and benefits of, such treat20 ments, including medications, are readily avail21 able. 

22 ‘‘(c) UPDATES.—Any significant update made to the 

23 strategy included in the report required by paragraph 

24 (2)(B) after such report is submitted shall be included in 


ssavage on LAPJG3WLY3PROD with BILLS
32 

HR 9598 RFS

1 the next National Drug Control Strategy submitted to 

2 Congress after such update is made.’’. 

3 (2) TECHNICAL AND CONFORMING AMEND4 MENT.—The Table of Contents for the Office of Na5 tional Drug Control Policy Reauthorization Act of 

6 2006 is amended by adding at the end the following 

7 new item: 

‘‘Sec. 1121. Requirement for Life Saving Opioid Overdose Reversal 

Study.’’. 

8 (f) REPORT ON PILL PRESS MACHINES.—Not later 

9 than 120 days after the date of the enactment of this Act, 

10 the Director of the Office of Drug Control Policy shall 

11 make public a report that includes an analysis of and a 

12 description of strategic ways to regulate the shipment of 

13 pill press machines and their critical parts using reports 

14 previously prepared by the Office. 

Passed the House of Representatives December 5, 

2024. 

Attest: KEVIN F. MCCUMBER, 

Clerk. 


ssavage on LAPJG3WLY3PROD with BILLS